ClinicalTrials.Veeva

Menu

Sedasys Post Approval Study Users Response to System Alarms

E

Ethicon

Status

Terminated

Conditions

Conscious Sedation

Treatments

Device: SEDASYS System

Study type

Observational

Funder types

Industry

Identifiers

NCT02573818
SED-14-001

Details and patient eligibility

About

The purpose of this study is to evaluate the users' responses to the SEDASYS® System alarms during esophagogastroduodenoscopy (EGD) or colonoscopy.

Enrollment

51 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • American Society of Anesthesiologists (ASA) I and II
  • male and female
  • Scheduled for routine colonoscopy or EGD
  • ≥18 years of age
  • Able to read, speak, and understand English

Exclusion criteria

  • Physical or psychological condition which would impair trial participation, at the discretion of the PI
  • BMI ≥ 35
  • Pregnancy or lactation
  • Known or suspected hypersensitivity to propofol or fentanyl
  • Use of a fentanyl patch
  • Allergies to eggs, egg products soybeans or soy products
  • Diagnosis of sleep apnea
  • Gastroparesis
  • Full stomach at the time of procedure
  • Participation in any other investigational device or drug study within 30 days of enrollment

Trial design

51 participants in 1 patient group

SEDASYS System
Treatment:
Device: SEDASYS System

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems